by In2Pharma | Mar 15, 2019 | News
The Netherlands Since February, all prescription medicines have a unique code and sealed packaging. The purpose of these safety features is to detect counterfeit medicines in the regular distribution channel. Any problem with the code or the seal can be reported...
by In2Pharma | Feb 12, 2019 | News
Belgium In light of the Falsified Medicines Directive, that came into effect on 9th February 2019, FAMHP has issued practical guidelines for the handling of complications during the initial phase of the new verification system. FAMHP and BeMVO have worked out an...
by In2Pharma | Dec 5, 2018 | News
The Netherlands As a result of the Falsified Medicines Directive, companies are obliged to adapt the packaging of their medicines which leads to additional costs. These additional costs cannot always be compensated by a price increase, due to the Drug Price Act (Wet...
by In2Pharma | Oct 26, 2018 | News
The Netherlands The Falsified Medicines Directive (FMD) (Directive 2011/62/EU) are measures to prevent falsified medicinal products for human use from entering the legal distribution chain. This includes that all outer packaging of prescription-only medicinal products...
by In2Pharma | Dec 6, 2017 | News
Luxembourg As from 9 February 2019, the Falsified Medicines Directive (FMD) will apply. Based on this, the Luxembourg National Medicines Verification Organisation (LMVO) will implement a Luxembourg verification system in cooperation with the Belgian National Medicines...
